|Bid||310.70 x 1100|
|Ask||310.89 x 800|
|Day's Range||309.66 - 338.50|
|52 Week Range||65.72 - 464.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||17.12|
|Earnings Date||Nov. 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||335.40|
Vaccinating Americans with their first or second shots is more urgent than giving boosters, according to one infectious disease expert, as unvaccinated individuals experience worse COVID-19 infection outcomes.
What happened Shares of several COVID-19 vaccine makers were sliding on Monday. BioNTech stock (NASDAQ: BNTX) was down 6.5% at 12:09 p.m. EDT. Shares of Moderna (NASDAQ: MRNA) had slipped 4.4%. Novavax (NASDAQ: NVAX) stock had fallen 6%.
BioNTech SE ( NASDAQ:BNTX ) shareholders have seen the share price descend 11% over the month. But that isn't a problem...